Clinical trials in Brno-Stred – page 22

In Brno-Stred, many trials focus on heart and blood vessel health, including heart failure, myocardial infarction, atrial fibrillation, atherosclerotic cardiovascular disease, and lipid disorders. The studies are largely aimed at testing new treatments, lowering cardiovascular risk, and improving outcomes after major cardiac events.

• Heart failure and prevention of worsening symptoms
• Myocardial infarction, stroke prevention, and post-event recovery
• Dyslipidemia, elevated Lp(a), and hypercholesterolemia
• Obesity, hypertension, and broader cardiometabolic risk

These trials also explore whether newer therapies can reduce inflammation and help prevent future cardiovascular complications.

Cancer research is a major part of the trial activity, covering breast cancer, lung cancer, ovarian cancer, prostate cancer, colorectal cancer, and several other advanced solid tumors. The main goal is to evaluate new cancer therapies, improve survival, and refine treatment options for difficult-to-treat disease.

• Breast cancer, including hormone receptor-positive and triple-negative disease
• Prostate cancer, renal cell carcinoma, and urothelial cancer
• Ovarian, cervical, endometrial, and gastric cancers
• Melanoma, lung cancer, and other advanced solid tumors

Many studies in the city are centered on immunotherapy, targeted treatment, and better maintenance strategies after standard therapy.

Clinical trials in this area address multiple sclerosis, Alzheimer’s disease, Parkinson disease, epilepsy, and mood or psychotic disorders linked to neurodegeneration. Researchers are seeking better symptom control, disease modification, and improved quality of life for patients with chronic brain and nervous system conditions.

• Multiple sclerosis and related inflammatory nervous system disease
• Alzheimer’s disease with agitation, psychosis, or early-stage cognitive decline
• Epilepsy and refractory seizure disorders
• Parkinson disease and other movement-related conditions

Several studies also examine brain inflammation and new approaches to managing neuropsychiatric symptoms.

Another strong research theme involves autoimmune and inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, psoriasis, and atopic dermatitis. These trials are designed to assess whether newer therapies can better control inflammation and reduce disease flares.

• Rheumatoid arthritis and axial spondyloarthritis
• Crohn’s disease and ulcerative colitis
• Psoriasis, atopic dermatitis, and chronic urticaria
• Lupus and other immune system diseases

These studies often compare newer immune therapies with existing treatment approaches to improve long-term disease control.

Trials in this group include studies on asthma, severe pneumonia, influenza, respiratory distress syndrome, and bacterial or viral infections. The research aims to improve prevention, reduce complications, and test treatments for serious infections affecting the lungs and airways.

• Asthma and other chronic respiratory conditions
• Severe pneumonia and acute respiratory distress syndrome
• Influenza prevention in older adults
• Bacterial infections, mycoses, and wound-related infection

Some studies also look at faster recovery and better protection against infection-related complications.

There is broad activity around digestive diseases and metabolism, including obesity, type 2 diabetes, gout, and hypertriglyceridemia. Several trials focus on improving symptom control, metabolic balance, and cardiovascular risk linked to these chronic conditions.

• Type 2 diabetes and weight-related complications
• Gout with elevated uric acid
• Crohn’s disease and ulcerative colitis
• Gastrointestinal cancers such as gastric and colorectal cancer

These studies combine treatment evaluation with a strong focus on long-term disease management.

Trials in this field address osteoarthritis, rheumatoid arthritis, axial spondyloarthritis, osteoporosis, and chronic pain conditions. The main objective is to ease pain, preserve function, and improve daily mobility for people with long-term joint and bone disorders.

• Knee osteoarthritis and chronic joint pain
• Rheumatoid arthritis and inflammatory joint disease
• Postmenopausal osteoporosis
• Chronic low back pain and psoriatic arthritis

Research here often compares symptom relief strategies and looks for safer, more durable pain control.

Several trials focus on diseases affecting the urinary and reproductive systems, including prostate cancer, bladder cancer, endometrial cancer, ovarian cancer, and endometriosis. The studies aim to improve treatment effectiveness, symptom relief, and reproductive health outcomes.

• Prostate cancer and bladder cancer
• Ovarian, endometrial, and cervical cancer
• Endometriosis and primary dysmenorrhea
• Contraception and pregnancy-related prevention studies

Some of the research also supports better management of hormone-related and pelvic pain conditions.

The city also hosts trials in less common conditions such as transthyretin amyloid cardiomyopathy, primary immunodeficiency diseases, hereditary angioedema, and myelofibrosis. These studies are typically aimed at testing new therapies for diseases with limited treatment options.

• ATTR-CM and other amyloid-related heart disorders
• Primary immunodeficiency diseases
• Hereditary angioedema
• Myelofibrosis and Langerhans cell histiocytosis

Such trials are especially important for patients who need more targeted care in specialized disease areas.

Research in skin and allergic diseases includes atopic dermatitis, chronic spontaneous urticaria, bullous pemphigoid, and seasonal allergic rhinitis. The purpose is to evaluate new ways to control itching, inflammation, and persistent allergic symptoms.

• Atopic dermatitis and chronic eczema-related disease
• Chronic spontaneous urticaria
• Bullous pemphigoid
• Allergic rhinitis and rhinoconjunctivitis

These studies aim to improve comfort and reduce the burden of recurring skin and allergy symptoms.

Several trials are directed at stroke, venous thromboembolism, pulmonary embolism, and other clot-related conditions. The research is focused on prevention, better treatment after acute events, and reducing the risk of recurrence.

• Ischemic stroke and high-risk transient ischemic attack
• Venous thromboembolism and pulmonary embolism
• Atrial fibrillation with stroke prevention
• Acute coronary syndromes linked to clot risk

These studies often examine whether newer medicines can offer safer long-term protection against major vascular events.

In addition to disease-specific work, there are trials addressing broader clinical problems such as sepsis, acute kidney injury, wound infection, urinary incontinence, and other pathological conditions. This research supports better management of complex patients across multiple specialties in Czechia.

• Sepsis-associated acute kidney injury
• Complicated surgical and traumatic wound infections
• Urinary incontinence and related symptoms
• General supportive care in medically complex illness

Overall, the trial portfolio in the city reflects a strong mix of prevention, treatment testing, and disease-management research.